Closed · EP-IDS-16-007 · CFDA 93.019 · Discretionary
Smallpox Research Oversight Activities: WHO Advisory Committee on Variola Virus Research
Federal grant opportunity posted by Assistant Secretary for Preparedness and Response, cataloged on Grants.gov.
- up to $300K
- Award range
- Closed
- Status
- August 22, 2016
- Close date
- 1
- Expected awards
The verdict
Smallpox Research Oversight Activities: WHO Advisory Committee on Variola Virus Research is a closed discretionary listing from Assistant Secretary for Preparedness and Response that offered Up to $300,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 66 other opportunities from Assistant Secretary for Preparedness and Response.
- up to $300K
- award range
- Closed
- application status
- 1
- expected award
- 93.019
- CFDA program
Archived opportunity record
Smallpox Research Oversight Activities: WHO A… is closed (last close August 22, 2016). Check the agency catalog for replacement NOFOs. Assistant Secretary for Preparedness and Response still indexes 66 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 22, 2016
Est. Total Funding
$300,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
Smallpox is an acute contagious disease caused by variola virus, a member of the Orthopoxvirus genus. It was one of the world's most feared diseases until it was eradicated by a collaborative global vaccination program led by the World Health Organization. The last known natural case was in Somalia in 1977. Upon eradication, all existing stockpiles of the virus were moved, by international agreement, to two œWHO International Collaborating Centers. The Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, USA, and the State Research Center of Virology and Biotechnology, Novosibirsk, Russia. Under this agreement, any and all work with variola virus by either group must be directly approved through an oversight committee established by the WHO. The WHO Advisory Committee on Variola Virus Research (ACVVR) was established in 1999 to determine what essential research, if any, must be carried out with live variola virus. The ACVVR monitored the research progress in order to reach global consensus on the timing for the destruction of existing variola virus stocks. In 2007, the World Health Assembly (WHA) requested the ACVVR undertake a thorough review of the approved research program with a report presented in 2010. The results were presented at the 64th WHA meeting in May of 2011. The ACVVR continues to serve a critically important function for global public health, and to oversee research. The U.S. Government supports the development of medical products, including vaccines and drugs, for use within the U.S. upon verification of a smallpox case. The U.S. government, through the Office of the Assistant Secretary for Preparedness and Response (ASPR), has successfully developed vaccine products, and is actively engaged in the development of several drug candidates for smallpox therapies, which require access to the variola virus to satisfy regulatory requirements for product approvals. The U.S. maintains a need to work directly with the virus for its strategic needs in developing medical countermeasures, such as safer vaccines, new antiviral agents, and better diagnostic systems as a defense against potential bioterrorism threats, thus strengthening our national security. A natural re-emergence of smallpox is not deemed possible, but if it were to occur as a result of a terrorist or deliberate event, it would be a potentially devastating threat to public health worldwide and would constitute a public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005). A case of smallpox detected by a member state requires notification to WHO as soon as possible, and any confirmed smallpox case would generate an immediate global public health response. Since May 1999, when the 52nd World Health Assembly (WHA) resolved to postpone the destruction of the variola virus to allow for this essential research (WHA 52.10), WHO has been charged with convening a group of experts to advise on the need for continuing such research, to review proposals for research involving viable variola virus, to review the progress of such research, and to report to the WHA each year. The need to support the activities described in this FOA has not changed. The variola virus research and stocks destruction are expected to be substantive agenda items at the 70th World Health Assembly in 2017. ASPR will provide a single source cooperative agreement to support the WHO Advisory Committee on Variola Virus Research to advise WHO on all activities in respect to variola virus research and the biosafety inspection of the variola virus repositories. The only eligible awardee is the World Health Organization (WHO). This FOA will only support non-research activities supported by HHS.
Catch-all / unrestricted eligibility mark · EP-IDS-16-007
Grants.gov marks Smallpox Research Oversight Activities: WHO A… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Assistant Secretary for Preparedness and Response book (28 peers, 42% of 67).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Grants.gov Contact Center Phone Number: 1-800-518-4726 Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. www.grants.gov
More from Assistant Secretary for Preparedness and Response
What to do next
Smallpox Research Oversight Activities: WHO A… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.019 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |